Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the company's ARIES® System and ARIES® HSV 1&2 Assay. ARIES® is a sample to answer system designed to increase ...
Dr. Stephen will cover the process of developing and manufacturing reliable Luminex biomarker assays, as well as using those assays to test samples. She will examine the development of Ampersand ...
As the use of engineered cells for the production of numerous research and clinical applications increases, the need to monitor multiple markers representing the stability and quality of the host cell ...
The in vitro diagnostics market has grown significantly in the past year, according to a recent report from PricewaterhouseCoopers, and will continue to do so well into the decade. Companies poised to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback